| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.02B | +37.3% |
| Cost of Revenue | $1.44B | +34.4% |
| Gross Profit | $587.4M | +45.2% |
| R&D Expense | $186.0M | +25.1% |
| SG&A Expense | $198.4M | +20.2% |
| Operating Income | $72.8M | +217.8% |
| Interest Expense | $38.1M | -39.1% |
| Pre-tax Income | -$84.4M | -220.2% |
| Income Tax | $2.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.45B | +205.7% |
| Accounts Receivable | $371.8M | +10.7% |
| Inventory | $643.3M | +18.1% |
| Current Assets | $3.73B | +82.5% |
| Total Assets | $4.40B | +65.5% |
| Current Liabilities | $623.8M | -2.0% |
| Long-term Debt | $2.62B | +131.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $113.9M | +23.9% |
| Capital Expenditures | $56.8M | -3.6% |
| Investing Cash Flow | -$93.1M | -58.4% |
| Financing Cash Flow | $1.51B | +760.9% |
| Free Cash Flow | $57.2M | +72.5% |
| +223.4% |
| Net Income | -$87.1M | -220.3% |
| EPS (Basic) | -$0.37 | -184.6% |
| EPS (Diluted) | -$0.37 | -184.6% |
| Total Liabilities |
| $3.60B |
| +73.9% |
| Stockholders' Equity | $768.6M | +36.7% |